As seen in Figure 2A, SUMO-conjugated TFAP2A was identified as a protein of approximately 55kD and is consistent with findings previously reported in breast and colon cancer cell lines [10, 13]. This evidence concerns the gene TFAP2A and malignant colon neoplasm.